Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma (Q83539279)
Jump to navigation
Jump to search
scientific article published on 29 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma |
scientific article published on 29 February 2012 |
Statements
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma (English)
R Maréchal
P Demetter
F Bonnetain
A Couvelard
M Svrcek
A Bardier-Dupas
C Louvet
F Paye
P Rougier
C Penna
J C Vaillant
J Closset
I Salmon
J F Emile
J L Van Laethem
29 February 2012
1 reference